Serosurvey of Haryana and Odisha: COVID-19 Hybrid Immunity

##plugins.themes.bootstrap3.article.main##

  •   Zameer Shervani

  •   Deepali Bhardwaj

  •   Roma Nikhat

  •   Aiman Ibbrahim

  •   Sadia Hasan

  •   Intazam Khan

  •   Umair Yaqub Qazi

  •   Adil Ahmed Khan

  •   Kehkeshan Fatma

  •   Yamin Siddiqui

  •   Ankira Agarwal

  •   Samar Siddiqui

  •   Shazma Khan

  •   Abdullah Sherwani

Abstract

The seroprevalence in Indian states Haryana and Odisha has been investigated. The seropositivity in the Haryana population increased with time from 8% to 14.8% to 76.3% as recorded in August, October 2020, and September 2021, respectively. The virus spread was continuous as the increase in seroprevalence was monotonous. The three COVID-19 pandemic waves that hit Haryana in September, November 2020, and May 2021 infected the population and generated antibodies. The last serosurvey conducted in September 2021 which registered 76.3% seroprevalence might have a contribution from vaccination as 25% of all the population was fully vaccinated and 60% had one dose. The seroprevalence in Odisha was found to be 20.8%, 68.1%, and 73% in the surveys conducted in August 2020, June, and August 2021, respectively. The survey conducted in Odisha in August 2021 found that 93% of the healthcare workers had antibodies suggested that in the general population also, 93% seroprevalence might be possible by strong vaccination drive or repeated virus exposure. A maximum seroprevalence of 75% was found in the age group of 19-44 years and the lowest of 66% was recorded among 60-plus individuals.


Keywords: Antibodies enhancement, Haryana serosurvey, hybrid immunity, Odisha serosurvey

References

The Indian Express. Two years of Covid-19 pandemic: Vaccines, pills, and a mutant in perspective. [Internet] [cited December 3, 2021].

The Japan Times. What's behind the rapid disappearance of the delta variant in Japan? It could be self-extinction. [Internet] [cited November 18, 2021].

The Japan Times. COVID-19 tracker: Japan logs 50 new cases for year's lowest daily total. [Internet] [cited November 22, 2021].

Coronavirus (COVID-19) - Google News. [Internet].

The Japan Times. Japan to take mix-and-match approach to COVID-19 booster shots. [Internet] [cited November 17, 2021].

The Japan Times. Japan's COVID-19 booster shot drive kicks off with health care workers. [Internet] [cited December 1, 2021].

The Asian Age. Active COVID-19 cases in country decline to 98,416, lowest in 552 days. [Internet] [cited December 6, 2021].

The Asian Age. Top scientists for COVID booster vaccine dose. [Internet] [cited December 3, 2021].

Hindustan Times. Canada health body recommends Covid booster shots for all adults. [Internet] [cited, December 3, 2021].

The Japan Times. Get a booster now and don’t wait for an omicron shot, experts say. [Internet] [cited December 3, 2021].

The Japan Times. Six vaccines show promise as boosters, led by mRNA shots. [internet] [cited December 3, 2021].

Shervani Z, Bhardwaj D, Nikhat R. Dharavi Slums (Mumbai, India): The Petri Dish of COVID-19 Herd Immunity. European Journal of Medical and Health Sciences. 2021; 3(3): 38-41.

Shervani Z. COVID-19 in Kerala: Health Index Theory. European Journal of Medical and Health Sciences. 2021; 3(2): 21-24.

Shervani Z. COVID-19 in Kerala: The Dynamics of Spread and Health Index Theory. RAS Medical Science. 2021;1(2): 1-3.

Shervani Z, Khan I, Siddiqui NY, Khan T, Qazi UY. Viability of SARS-CoV-2 and Sanitization Methods. European Journal of Medical and Health Sciences. 2021; 3(1): 22-27.

Z. Shervani, I. Khan, N. Y. Siddiqui, T. Khan and U. Y. Qazi, Risk of SARS-CoV-2 Transmission from Humans to Pets and Vice Versa. European Journal of Medical and Health Sciences. 2021;3(1): 34-38.

Shervani Z, Khan I, Qazi UY. SARS-CoV-2 delayed Tokyo 2020 Olympics: Very recent advances in covid-19 detection, treatment, and vaccine development useful conducting the games in 2021. Advances in Infectious Diseases. 2020; 10(3): 56-66.

Shervani Z, Khan I, Qazi UY. COVID-19 vaccine. Advances in Infectious Diseases. 2020; 10(3): 195-210.

Shervani Z, Khan I, Khan T, Qazi UY. World’s fastest supercomputer picks COVID-19 drug. Advances in Infectious Diseases. 2020; 10(3): 211-225.

Shervani Z, Bhardwaj D, Sherwani A, Khan I, Qazi UY. COVID-19 infection in 8 big cities of India: The Dynamics of the Spread and Seropositivity. European Journal of Medical and Health Sciences. 2021; 3(6): 1-5.

Shervani Z, Bhardwaj D, Nikhat R. COVID-19 infection in India: Seropositivity versus the Dynamics of the Spread. European Journal of Medical and Health Sciences. 2021; 3(4): 95-99.

The Times of India. Antibodies against Covid-19 found in 76.3% people in Haryana, says Anil Vij. [Internet] [cited October 18, 2021].

The Indian Express. Three of every four persons in Haryana has Covid antibodies. [Internet] [cited October 19, 2021].

Coronavirus: At least 73% of Odisha’s population has antibodies, shows sero survey. [Internet] [cited, September 27, 2021] Available from: scroll.in.

% population of Odisha has antibodies against Covid: ICMR survey. [internet] [cited September 27, 2021] Business Standard, Available from: business-stadard.com.

Kshatri JS, Bhattacharya D, Kanungo S, Giri S, Palo SK, Parai D, et al. Serological surveys to inform SARS‑CoV‑2 epidemic curve: a cross‑sectional study from Odisha, India, Scientific Reports. 2021; 11: 10551.

Hindustan Times. Over 85% healthcare workers in 3 Odisha districts developed Covid-19 antibodies. [Internet] [cited July 24, 2021].

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

How to Cite
Shervani, Z., Bhardwaj, D. ., Nikhat, R., Ibbrahim, A. ., Hasan, S., Khan, I., Qazi, U. Y., Khan, A. A., Fatma, K., Siddiqui, Y., Agarwal, A. ., Siddiqui, S., Khan, S., & Sherwani, A. (2022). Serosurvey of Haryana and Odisha: COVID-19 Hybrid Immunity. European Journal of Medical and Health Sciences, 4(2), 27–32. https://doi.org/10.24018/ejmed.2022.4.2.1173

Most read articles by the same author(s)

1 2 > >>